| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005893 | Clinical Therapeutics | 2005 | 11 Pages |
Abstract
In this 2-week study in patients with moderate to severe SAR, azelastine nasal spray was well tolerated and produced significantly greater improvements in TNSS and total RQLQ score compared with cetirizine.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Corren, MD Storms, MD Bernstein, MD Berger, MD Nayak, MD Sacks, The Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group The Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group,